Clinical and microbiological characteristics of Flavobacterium indologenes infections associated with indwelling devices

Journal of Clinical Microbiology

Volumn 34, Issue 8, 1996, Pages 1908-1913

  Hsueh, Po Ren ^a   Teng, Lee Jene ^b   Ho, Shen Wu ^b   Hsieh, Wei Chuan ^a   Luh, Kwen Tay ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AZTREONAM; CEFALOTIN; CEFOPERAZONE; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; IMIPENEM; LATAMOXEF; MINOCYCLINE; NETILMICIN; OFLOXACIN; PIPERACILLIN; TEICOPLANIN; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIUM IDENTIFICATION; CATHETER INFECTION; CHILD; CLINICAL ARTICLE; FEMALE; FLAVOBACTERIUM; HUMAN; INDWELLING CATHETER; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RANDOM AMPLIFIED POLYMORPHIC DNA;

BACTERIA (MICROORGANISMS); CHRYSEOBACTERIUM INDOLOGENES; FLAVOBACTERIUM;

EID: 0029950765     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.34.8.1908-1913.1996     Document Type: Article

References (32)

1. Aber, R. C., C. Wennersten, and R. C. Moellering, Jr. 1978. Antimicrobial susceptibility of flavobacteria. Antimicrob. Agents Chemother. 14:483-487.
2. Cabrera, H. A., and G. H. Davis. 1961. Epidemic meningitis of the newborn caused by flavobacteria: epidemiology and bacteriology. Am. J. Dis. Child. 101:289-295.
3. Chatelut, M., J. L. Dournes, G. Chabanon, and N. Marty. 1995. Epidemiological typing of Stenotrophomonas (Xanthomonas) maltophilia by PCR. J. Clin. Microbiol. 33:912-914.
4. Dees, S. B., C. W. Moss, D. G. Hollis, and R. E. Weaver. 1986. Chemical characterization of Flavobacterium odoratum, Flavobacterium breve, and Flavobacterium-like groups IIe, IIh, and IIf. J. Clin. Microbiol. 23:267-273.
5. Dickinson, G. M., and A. L. Bisno. 1989. Infections associated with indwelling devices: concepts of pathogenesis; infections associated with intravascular devices. Antimicrob. Agents Chemother. 33:597-601.
6. Dickinson, G. M., and A. L. Bisno. 1989. Infections associated with indwelling devices: infections related to extravascular devices. Antimicrob. Agents Chemother. 33:602-607.
7. George, R. M., C. P. Cochran, and W. E. Wheeler. 1961. Epidemic meningitis of the newborn caused by flavobacteria: clinical manifestation and treatment. Am. J. Dis. Child. 101:296-304.
8. Harvey, W. H., T. E. Pick, K. Reed, and R. I. Solenberger. 1989. A prospective evaluation of the Port-A-Cath implantable venous access system in chronically ill adults and children. Surg. Gynecol. Obstet. 169:495-500.
9. Holmes, B. 1987. Identification and distribution of Flavobacterium meningosepticum in clinical material. J. Appl. Bacteriol. 62:29-41.
10. Holmes, B., R. J. Owen, A. G. Steigerwalt, and D. J. Brenner. 1984. Flavobacterium gleum, a new species found in human clinical specimens. Int. J. Syst. Bacteriol. 34:21-25.
11. Jorgensen, J. H., L. A. Maher, and A. W. Howell. 1991. Activity of meropenem against antibiotic-resistant or infrequently encountered gram-negative bacilli. Antimicrob. Agents Chemother. 35:2410-2414.
12. Khatib, R., K. M. Riederer, J. A. Clark, S. Khatib, L. E. Briski, and F. M. Wilson. 1995. Coagulase-negative staphylococci in multiple blood cultures: strain relatedness and determinants of same-strain bacteremia. J. Clin. Microbiol. 33:815-820.
13. Microbial ID Inc. 1992. Microbial identification system operational manual, version 4. Microbial ID Inc., Newark, Del.
14. Mobley, H. L. T., M. G. Chippendale, J. M. Tenney, R. A. Hull, and J. W. Warren. 1987. Expression of type I fimbriae may be required for persistence of E. coli in the catheterized urinary tract. J. Clin. Microbiol. 25:2253-2257.
15. Moss, C. W., and S. B. Dees. 1978. Cellular fatty acids of Flavobacterium meningosepticum and Flavobacterium species group IIb. J. Clin. Microbiol. 8:772-774.
16. National Committee for Clinical Laboratory Standards. 1993. Methods for dilution antimicrobial susceptibility testing for bacteria that grow aerobically. Approved standard M7-A3. National Committee for Clinical Laboratory Standards, Villanova, Pa.
17. Onderdonk, A. B., and M. Sasser. 1995. Gas-liquid and high-performance liquid chromatographic methods for the identification of microorganisms, p. 123-129. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed), Manual of clinical microbiology, 6th ed. American Society for Microbiology, Washington, D.C.
18. Pederson, M. M., E. Marso, and M. J. Pickett. 1970. Nonfermentative bacilli associated with man. III. Pathogenicity and antibiotic susceptibility. Am. J. Clin. Pathol. 54:178-192.
19. Raimondi, A., F. F. Moosdeen, and J. D. Williams. 1986. Antibiotic resistance pattern of Flavobacterium meningosepticum. Eur. J. Clin. Microbiol. Infect. Dis. 5:461-463.
20. Rizzari, C., G. Palamone, A. Corbetta, C. Uderzo, and E. F. Vigano. 1992. Central venous catheter-related infections in pediatric hematology-oncology patients: role of home and hospital management. Pediatr. Hematol. Oncol. 9:115-123.
21. Salata, R. A., M. M. Lederman, and D. M. Shales. 1987. Diagnosis of nosocomial pneumonia in intubated, intensive care unit patients. Am. Rev. Respir. Dis. 135:426-432.
22. Siegman-Igra, Y., D. Schwaqrtz, G. Soferman, and N. Konforki. 1987. Flavobacterium group IIb bacteremia: report of a case and review of Flavobacterium infections. Med. Microbiol. Immunol. 176:103-111.
23. Stamm, W. E., J. J. Colella, R. L. Anderson, and R. E. Dixon. 1975. Indwelling arterial catheter as a source of nosocomial bacteremia: an outbreak caused by Flavobacterium species. N. Engl. J. Med. 292:1099-1102.
24. Strandberg, D. A., J. H. Jorgensen, and D. J. Drutz. 1983. Activity of aztreonam and new cephalosporins against infrequently isolated gram-negative bacilli. Antimicrob. Agents Chemother. 24:282-286.
25. von Graevenitz, A. 1995. Acinetobacter, Alcaligenes, Moraxella, and other nonfermentative gram-negative bacteria, p. 520-532. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed), Manual of clinical microbiology, 6th ed. American Society for Microbiology, Washington, D.C.
26. von Graevenitz, A., and M. Grehn. 1977. Susceptibility studies on Flavobacterium II-b. FEMS Microbiol. Lett. 2:289-292.
27. Warren, J. W. 1986. Providencia stuartii: a common cause of antibiotic-related bacteriuria in patients with long-term indwelling catheters. Rev. Infect. Dis. 8:61-67.
28. Warren, J. W., J. H. Jenney, J. M. Hoopes, H. L. Muncie, and W. C. Anthony. 1982. A prospective microbiologic study of bacteriuria in patients with chronically indwelling urethral catheters. J. Infect. Dis. 146:719-723.
29. Wesenberg, F., H. Flaatten, and C. W. Janssen, Jr. 1993. Central venous catheter with subcutaneous injection port (Port-A-Cath): 8 years clinical follow up with children. Pediatr. Hematol. Oncol. 10:233-239.
30. Williams, J. G. K., A. R. Kubelik, K. J. Livak, J. A. Rafalski, and S. V. Tingey. 1990. DNA polymorphisms amplified by arbitrary primers are useful as genetic markers. Nucleic Acids Res. 18:6531-6535.
31. Yabuuchi, E., Y. Hashimoto, T. Ezaki, Y. Ido, and N. Takeuchi. 1990. Genotypic and phenotypic differentiation of Flavobacterium indologenes Yabuuchi et al 1983 from Flavobacterium gleum Holmes et al 1984. Microbiol. Immunol. 34:73-76.
32. Yabuuchi, E., T. Kaneko, I. Yano, C. W. Moss, and N. Miyoshi. 1983. Sphingobacterium gen. nov., Sphingobacterium spiritivorum comb. nov., Sphingobacterium multivorum comb. nov., Sphingobacterium mizutae sp. nov., and Flavobacterium indologenes sp. nov.: glucose-nonfermenting, gram-negative rods in CDC group IIk-2 and IIb. Int. J. Syst. Bacteriol. 33:580-598.